USPIO-Enhanced MRI Neuroimaging: A Review

Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging

(2015) Robert J. McDonald et al.   RADIOLOGY

Phagocytosis of Microglia in the Central Nervous System Diseases

(2014) Ruying Fu et al.   MOLECULAR NEUROBIOLOGY

Nanotechnologies for the study of the central nervous system

(2014) A. Ajetunmobi et al.   PROGRESS IN NEUROBIOLOGY

Molecular magnetic resonance imaging of brain–immune interactions

(2014) Maxime Gauberti et al.   Frontiers in Cellular Neuroscience

The Controversial Role of Microglia in Malignant Gliomas

(2013) Jun Wei et al.   Clinical & Developmental Immunology

Nanoparticle-Based Systems for T1-Weighted Magnetic Resonance Imaging Contrast Agents

(2013) Derong Zhu et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

High-Resolution Steady-State Cerebral Blood Volume Maps in Patients with Central Nervous System Neoplasms Using Ferumoxytol, a Superparamagnetic Iron Oxide Nanoparticle

(2013) Csanad G Varallyay et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

The Emerging Role of Ferumoxytol-Enhanced MRI in the Management of Cerebrovascular Lesions

(2013) Nohra Chalouhi et al.   MOLECULES

Using iron oxide nanoparticles to diagnose CNS inflammatory diseases and PCNSL

(2013) B. T. Farrell et al.   NEUROLOGY

Macrophage Imaging Within Human Cerebral Aneurysms Wall Using Ferumoxytol-Enhanced MRI: A Pilot Study

(2012) David M. Hasan et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

MRI Assessment of Hepatic Iron Clearance Rates After USPIO Administration in Healthy Adults

(2012) Pippa Storey et al.   INVESTIGATIVE RADIOLOGY

Ferumoxytol in clinical practice: Implications for MRI

(2012) Brendan J. McCullough et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Contrast-enhanced functional blood volume imaging (CE-fBVI): Enhanced sensitivity for brain activation in humans using the ultrasmall superparamagnetic iron oxide agent ferumoxytol

(2012) Deqiang Qiu et al.   NEUROIMAGE

Assessment of Disease Activity in Multiple Sclerosis Phenotypes with Combined Gadolinium- and Superparamagnetic Iron Oxide–enhanced MR Imaging

(2012) Thomas Tourdias et al.   RADIOLOGY

Early Change in Ferumoxytol-Enhanced Magnetic Resonance Imaging Signal Suggests Unstable Human Cerebral Aneurysm

(2012) David Hasan et al.   STROKE

Ferumoxytol-Enhanced MRI to Image Inflammation Within Human Brain Arteriovenous Malformations: a Pilot Investigation

(2012) David M. Hasan et al.   Translational Stroke Research

Comparative Analysis of Ferumoxytol and Gadoteridol Enhancement Using T1- and T2-Weighted MRI in Neuroimaging

(2011) Bronwyn E. Hamilton et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

MRI Using Ferumoxytol Improves the Visualization of Central Nervous System Vascular Malformations

(2011) Edit Dósa et al.   STROKE

Potential for Differentiation of Pseudoprogression From True Tumor Progression With Dynamic Susceptibility-Weighted Contrast-Enhanced Magnetic Resonance Imaging Using Ferumoxytol vs. Gadoteridol: A Pilot Study

(2010) Seymur Gahramanov et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Magnetic resonance imaging of intracranial tumors: intra-patient comparison of gadoteridol and ferumoxytol

(2010) E. Dosa et al.   NEURO-ONCOLOGY

Dynamic MRI Using Iron Oxide Nanoparticles to Assess Early Vascular Effects of Antiangiogenic versus Corticosteroid Treatment in a Glioma Model

(2009) Csanad G Varallyay et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Superparamagnetic Iron Oxide Nanoparticles: Diagnostic Magnetic Resonance Imaging and Potential Therapeutic Applications in Neurooncology and Central Nervous System Inflammatory Pathologies, a Review

(2009) Jason S Weinstein et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Use of ultrasmall superparamagnetic particles of iron oxide (USPIO)-enhanced MRI to demonstrate diffuse inflammation in the normal-appearing white matter (NAWM) of multiple sclerosis (MS) patients: An exploratory study

(2009) Machteld M. Vellinga et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Biodistribution of gadolinium-based contrast agents, including gadolinium deposition

(2009) Silvio Aime et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement

(2008) Machteld M. Vellinga et al.   BRAIN

Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)?

(2008) Edward A. Neuwelt et al.   KIDNEY INTERNATIONAL